Allurion Technologies, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
Allurion Technologies, Inc. (ALUR) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of -6.00% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2026-03-30
- Allurion Technologies, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2024 was -6.00%.
- Allurion Technologies, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2023 was -0.80%.
- Allurion Technologies, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2022 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | -6.00% 10-K · filed 2026-03-30 | -1.50% 10-K · filed 2025-03-27 |
| 2023-12-31 | -0.80% 10-K/A · filed 2025-08-28 | -0.90% 10-K · filed 2024-03-26 |
| 2022-12-31 | 0.00% 10-K/A · filed 2025-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |